AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 6124236 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 48
Study 31771991 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile low-dose CT screening unit
Number of subjects: 550
Study 30414600 — intervention group
Group type: EXPERIMENTAL
Intervention: Fundal dominant contractions (F dominance)
Number of subjects: 224
Study 28691473 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacteriotherapy (Lactobacillus Reuteri DSM 17938 and Lactobaciullus Reuteri ATCC PTA 5289)
Number of subjects: 80
Study 28691473 — intervention group
Group type: COMPARATOR
Intervention: Oral hygiene instructions only (Control)
Number of subjects: 80
Study 25741580 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic-containing lozenges
Number of subjects: 30
Study 25741580 — intervention group
Group type: COMPARATOR
Intervention: Placebo lozenges
Number of subjects: 30
Study 23446957 — intervention group
Group type: EXPERIMENTAL
Intervention: losartan 50 mg
Number of subjects: 88
Study 23446957 — intervention group
Group type: EXPERIMENTAL
Intervention: losartan 50 mg/hydrochlorothiazide (HCTZ) 12.5 mg
Number of subjects: 88
Study 23446957 — intervention group
Group type: EXPERIMENTAL
Intervention: amlodipine 5 mg
Number of subjects: 88
Study 23446957 — intervention group
Group type: EXPERIMENTAL
Intervention: amlodipine 10 mg
Number of subjects: 88
Study 21144753 — intervention group
Group type: EXPERIMENTAL
Intervention: Optokinetic stimulation (OKS) exposure for five consecutive days
Number of subjects: 26
Study 21144753 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 26
Study 18037544 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 microg vaccine
Number of subjects: 48
Study 18037544 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 microg vaccine
Number of subjects: 48
Study 18037544 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 microg vaccine
Number of subjects: 48
Study 18037544 — intervention group
Group type: COMPARATOR
Intervention: Four low doses of 2.5 microg
Number of subjects: 48
Study 18037544 — intervention group
Group type: COMPARATOR
Intervention: Four low doses of 5 microg
Number of subjects: 48
Study 17172187 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifaximin 200 (2 cp bid for ten days in a month) followed by Bifidobacterium longum W11 (one granulated suspension for 6 days on alternate weeks)
Number of subjects: 70
Study 17172187 — intervention group
Group type: COMPARATOR
Intervention: Rifaximin 200 (2 cp bid for ten days in a month)
Number of subjects: 70
Study 14519566 — intervention group
Group type: EXPERIMENTAL
Intervention: Uncomplicated epilepsy group
Number of subjects: 440
Study 14519566 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 440
Study 10765078 — intervention group
Group type: EXPERIMENTAL
Intervention: Percent free prostate-specific antigen (PSA)
Number of subjects: 257
Study 9206199 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-lipid A of LPS antibody (anti-LPS treatment group)
Number of subjects: 19
Study 9206199 — intervention group
Group type: COMPARATOR
Intervention: Nontreated group
Number of subjects: 19
Study 1728077 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine (100 mg intravenously every 12 hours for 72 hours)
Number of subjects: 26
Study 1728077 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 6383045 — intervention group
Group type: EXPERIMENTAL
Intervention: Ritodrine, 120 mg daily (oral)
Number of subjects: 100
Study 6383045 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline, 30 mg daily (oral)
Number of subjects: 100
Study 6383045 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline (oral)
Number of subjects: 100
Study 6383045 — intervention group
Group type: EXPERIMENTAL
Intervention: Ritodrine (oral)
Number of subjects: 100
Study 6383045 — intervention group
Group type: EXPERIMENTAL
Intervention: Ritodrine (intravenous)
Number of subjects: 100
Study 6383045 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline (intravenous)
Number of subjects: 100
Study 6383045 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline (serum glucose)
Number of subjects: 100
Study 6383045 — intervention group
Group type: EXPERIMENTAL
Intervention: Ritodrine (serum glucose)
Number of subjects: 100
Study 30226299 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical exercise during the first 2 hours of hemodialysis sessions
Number of subjects: 69
Study 30226299 — intervention group
Group type: COMPARATOR
Intervention: Home exercise
Number of subjects: 69
Study 29959722 — intervention group
Group type: EXPERIMENTAL
Intervention: NIDA Standard education intervention
Number of subjects: 400
Study 29959722 — intervention group
Group type: EXPERIMENTAL
Intervention: NIDA Standard plus motivational interviewing (MI-HIV)
Number of subjects: 400
Study 26930488 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist-Assisted Internet-delivered Cognitive Behavior Therapy (TA-ICBT)
Number of subjects: 50
Study 26930488 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 50
Study 26930488 — intervention group
Group type: EXPERIMENTAL
Intervention: TA-ICBT
Number of subjects: 50
Study 24290850 — intervention group
Group type: EXPERIMENTAL
Intervention: cVEMP (ipsilateral i-p13/n23 and contralateral c-n12/p24/n30)
Number of subjects: 16
Study 24290850 — intervention group
Group type: EXPERIMENTAL
Intervention: oVEMP (contralateral c-n10/p16/n21 and ipsilateral i-n13)
Number of subjects: 16
Study 24290850 — intervention group
Group type: EXPERIMENTAL
Intervention: SCD patient responses
Number of subjects: 16
Study 24290850 — intervention group
Group type: EXPERIMENTAL
Intervention: cVEMP potentials
Number of subjects: 16
Study 24290850 — intervention group
Group type: EXPERIMENTAL
Intervention: oVEMP c-n10, p16 and n21 potentials
Number of subjects: 16
Study 22918303 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline GDF‐15 concentration
Number of subjects: 496
Study 22918303 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in GDF‐15 from baseline to 4 years
Number of subjects: 496
Study 22918303 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline GDF‐15
Number of subjects: 496
Study 22918303 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline GDF‐15 after multivariate adjustment
Number of subjects: 496
Study 21051772 — intervention group
Group type: EXPERIMENTAL
Intervention: Fall prevention intervention
Number of subjects: 543
Study 21051772 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 543
Study 17484003 — intervention group
Group type: EXPERIMENTAL
Intervention: BRAVO catheter‐free pH monitoring
Number of subjects: 133
Study 17484003 — intervention group
Group type: COMPARATOR
Intervention: Conventional 24‐h pH monitoring
Number of subjects: 133
Study 15789585 — intervention group
Group type: EXPERIMENTAL
Intervention: Free breathing
Number of subjects: 60
Study 15789585 — intervention group
Group type: EXPERIMENTAL
Intervention: Audio instruction
Number of subjects: 60
Study 15789585 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual feedback
Number of subjects: 60
Study 15789585 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined motion measurements for all patients
Number of subjects: 60
Study 11181239 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen therapy at a mean flow rate of 1.3 +/- 0.4 l/min
Number of subjects: 10
Study 11181239 — intervention group
Group type: COMPARATOR
Intervention: Air administered at the same flow rate
Number of subjects: 10
Study 11181239 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen therapy
Number of subjects: 10
Study 10771881 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone plus dexamethasone i.v.
Number of subjects: 77
Study 10771881 — intervention group
Group type: COMPARATOR
Intervention: Ceftriaxone alone
Number of subjects: 77
Study 7910230 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard treatment with PSK (protein‐bound polysaccharide)
Number of subjects: 262
Study 7910230 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment alone (mitomycin plus oral fluorouracil)
Number of subjects: 262
Study 2967433 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin-dipyridamole combination (330 mg-75 mg) given three times daily, with intravenous dipyridamole at 10 mg per hour for 24 hours before PTCA.
Number of subjects: 376
Study 2967433 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 376
Study 2967433 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin-dipyridamole combination (active drug)
Number of subjects: 376
Study 31959416 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasmapheresis and aggressive fluid resuscitation
Number of subjects: 495
Study 31959416 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin and heparin treatment with aggressive fluid resuscitation
Number of subjects: 495
Study 31959416 — intervention group
Group type: COMPARATOR
Intervention: Aggressive fluid resuscitation
Number of subjects: 495
Study 29369834 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral 3% hypertonic saline (HTS)
Number of subjects: 20
Study 29369834 — intervention group
Group type: COMPARATOR
Intervention: IV 3% hypertonic saline (HTS)
Number of subjects: 20
Study 27240822 — intervention group
Group type: EXPERIMENTAL
Intervention: Side-to-end anastomosis
Number of subjects: 86
Study 27240822 — intervention group
Group type: COMPARATOR
Intervention: Straight anastomosis
Number of subjects: 86
Study 26220439 — intervention group
Group type: EXPERIMENTAL
Intervention: Plum-blossom needle therapy
Number of subjects: 60
Study 26220439 — intervention group
Group type: COMPARATOR
Intervention: Habit reversal training (HRT)
Number of subjects: 60
Study 23897332 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine in infiltration solution
Number of subjects: 0
Study 23897332 — intervention group
Group type: COMPARATOR
Intervention: Control (infiltration solution without lidocaine)
Number of subjects: 0
Study 19952802 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative intervention for chronic pain
Number of subjects: 401
Study 19952802 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 401
Study 18266204 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality improvement intervention for CRC screening (2003)
Number of subjects: 980
Study 18266204 — intervention group
Group type: EXPERIMENTAL
Intervention: Discussion of CRC with a doctor
Number of subjects: 980
Study 18266204 — intervention group
Group type: EXPERIMENTAL
Intervention: Reporting barriers to CRC screening
Number of subjects: 980
Study 16507188 — intervention group
Group type: EXPERIMENTAL
Intervention: Levobupivacaine 0.5%
Number of subjects: 208
Study 16507188 — intervention group
Group type: COMPARATOR
Intervention: Ropivacaine 0.75%
Number of subjects: 208
Study 14620619 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard triple therapy plus bovine lactoferrin (group A)
Number of subjects: 150
Study 14620619 — intervention group
Group type: COMPARATOR
Intervention: Standard triple therapy (group B)
Number of subjects: 150
Study 14620619 — intervention group
Group type: COMPARATOR
Intervention: 10-day standard triple therapy (group C)
Number of subjects: 150
Study 10489003 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous test protocol (n = 10)
Number of subjects: 20
Study 10489003 — intervention group
Group type: COMPARATOR
Intervention: Separate test protocol (n = 10)
Number of subjects: 20
Study 9219143 — intervention group
Group type: EXPERIMENTAL
Intervention: Inpatient detoxification for cocaine withdrawal
Number of subjects: 0
Study 1767541 — intervention group
Group type: EXPERIMENTAL
Intervention: Subtotal parathyroidectomy (sPTX)
Number of subjects: 40
Study 1767541 — intervention group
Group type: COMPARATOR
Intervention: Total parathyroidectomy and autotransplantation (PTX + AT)
Number of subjects: 40
Study 7036283 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg poly A‐poly U i.v. once a week for 6 weeks
Number of subjects: 300
Study 7036283 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 300
Study 29203151 — intervention group
Group type: EXPERIMENTAL
Intervention: ADV6209 (2mg/ml oral solution of midazolam containing cyclodextrin)
Number of subjects: 49
Study 27183932 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical students
Number of subjects: 1888
Study 27183932 — intervention group
Group type: COMPARATOR
Intervention: General education students
Number of subjects: 1888
Study 23950550 — intervention group
Group type: EXPERIMENTAL
Intervention: Fingolimod 0.5 mg
Number of subjects: 1272
Study 23950550 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1272
Study 22851406 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab
Number of subjects: 0
Study 22851406 — intervention group
Group type: COMPARATOR
Intervention: Zoledronic acid
Number of subjects: 0
Study 20415574 — intervention group
Group type: EXPERIMENTAL
Intervention: Early ART (within 72 hours after CM diagnosis)
Number of subjects: 54
Study 20415574 — intervention group
Group type: COMPARATOR
Intervention: Delayed ART (after 10 weeks of treatment with fluconazole alone)
Number of subjects: 54
Study 18711184 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine plus Paclitaxel (GT)
Number of subjects: 529
Study 18711184 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel
Number of subjects: 529
Study 16779159 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital pen and paper system
Number of subjects: 21
Study 16779159 — intervention group
Group type: COMPARATOR
Intervention: Conventional pens
Number of subjects: 21
Study 12351537 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin (NTG) patch administered the day before embryo transfer and continued until pregnancy test results or menstruation
Number of subjects: 138
Study 12351537 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 138
Study 10078577 — intervention group
Group type: EXPERIMENTAL
Intervention: Water-gymnastics
Number of subjects: 258
Study 10078577 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 258
Study 7781399 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy (RT) alone preoperatively or postoperatively
Number of subjects: 0
Study 7781399 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative or postoperative RT
Number of subjects: 0
Study 7781399 — intervention group
Group type: COMPARATOR
Intervention: RT alone
Number of subjects: 0
Study 7781399 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent chemotherapy and RT
Number of subjects: 0
Study 7781399 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined modality of RT and chemotherapy
Number of subjects: 0
Study 2111239 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin treatment for 4 weeks
Number of subjects: 18
Study 2111239 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 18
Study 6108779 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam 2 mg
Number of subjects: 0
Study 6108779 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam 4 mg
Number of subjects: 0
Study 6108779 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam 2 mg + Morphine 5 mg
Number of subjects: 0
Study 6108779 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam 4 mg + Morphine 5 mg
Number of subjects: 0
Study 6108779 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam 2 mg and 4 mg
Number of subjects: 0
Study 6653648 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazoxide 150 mg
Number of subjects: 25
Study 6653648 — intervention group
Group type: COMPARATOR
Intervention: Labetalol 50 mg
Number of subjects: 25
Study 30915467 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid-based nutrient supplement (LNS) provided daily during pregnancy and first 6 months postpartum, and to infants from age 6 to 18 months.
Number of subjects: 775
Study 30915467 — intervention group
Group type: COMPARATOR
Intervention: Non-LNS group received daily iron and folic acid or multiple micronutrients during pregnancy and first 6 months postpartum, with no infant supplementation.
Number of subjects: 775
Study 30915467 — intervention group
Group type: EXPERIMENTAL
Intervention: LNS group among children with reliable responses.
Number of subjects: 775
Study 30915467 — intervention group
Group type: COMPARATOR
Intervention: Non-LNS group among children with reliable responses.
Number of subjects: 775
Study 30018175 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical Insufflation-Exsufflation (MI-E) during respiratory physiotherapy
Number of subjects: 90
Study 30018175 — intervention group
Group type: COMPARATOR
Intervention: Standard respiratory physiotherapy alone (Control)
Number of subjects: 90
Study 27085586 — intervention group
Group type: EXPERIMENTAL
Intervention: PF‐06260414 (1 to 400 mg for SAD, 3 to 100 mg BID for MAD, 60 mg once-daily, 30 mg BID for Japanese cohort)
Number of subjects: 31
Study 27085586 — intervention group
Group type: COMPARATOR
Intervention: PF‐06260414 (100 mg BID)
Number of subjects: 31
Study 27085586 — intervention group
Group type: EXPERIMENTAL
Intervention: PF‐06260414
Number of subjects: 31
Study 24185642 — intervention group
Group type: EXPERIMENTAL
Intervention: Face-to-face information combined with a booklet (Back Book)
Number of subjects: 181
Study 24185642 — intervention group
Group type: COMPARATOR
Intervention: Booklet alone
Number of subjects: 181
Study 22584452 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetostrictive ultrasonic instruments
Number of subjects: 18
Study 22584452 — intervention group
Group type: COMPARATOR
Intervention: Piezoelectric ultrasonic instruments
Number of subjects: 18
Study 20335313 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 18612863 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinician-assisted computerized cognitive behavioural treatment programme
Number of subjects: 88
Study 18612863 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 88
Study 16038711 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiplatelet therapy (APT)
Number of subjects: 427
Study 16038711 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral anticoagulants (OAC)
Number of subjects: 427
Study 16038711 — intervention group
Group type: COMPARATOR
Intervention: No antiplatelet therapy (control group)
Number of subjects: 427
Study 16038711 — intervention group
Group type: COMPARATOR
Intervention: No oral anticoagulants (control group)
Number of subjects: 427
Study 12394349 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual genetic risk counseling
Number of subjects: 357
Study 12394349 — intervention group
Group type: EXPERIMENTAL
Intervention: Group psychosocial counseling
Number of subjects: 357
Study 12394349 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 357
Study 10530833 — intervention group
Group type: EXPERIMENTAL
Intervention: Knees with ACL loss
Number of subjects: 35
Study 10530833 — intervention group
Group type: COMPARATOR
Intervention: Undamaged knees of patients
Number of subjects: 35
Study 10530833 — intervention group
Group type: COMPARATOR
Intervention: Control group knees
Number of subjects: 35
Study 7621766 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief infrared laser heat pulses applied to the right temple
Number of subjects: 10
Study 2025015 — intervention group
Group type: EXPERIMENTAL
Intervention: MMR II
Number of subjects: 77
Study 2025015 — intervention group
Group type: COMPARATOR
Intervention: Pluserix
Number of subjects: 77
Study 7249316 — intervention group
Group type: EXPERIMENTAL
Intervention: New procedure (minimal right ventriculotomy and pulmonary valve repair)
Number of subjects: 42
Study 7249316 — intervention group
Group type: COMPARATOR
Intervention: Conventional procedure (right ventriculotomy without pulmonary valve repair)
Number of subjects: 42
Study 31244487 — intervention group
Group type: EXPERIMENTAL
Intervention: TheraSling therapy (TST) combined with neuromuscular facilitation technique
Number of subjects: 56
Study 31244487 — intervention group
Group type: COMPARATOR
Intervention: Neuromuscular facilitation technique (Control)
Number of subjects: 56
Study 28361235 — intervention group
Group type: EXPERIMENTAL
Intervention: DASH diet
Number of subjects: 103
Study 28361235 — intervention group
Group type: COMPARATOR
Intervention: Typical American diet (control)
Number of subjects: 103
Study 25072405 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy administered over the telephone (CBT-T)
Number of subjects: 100
Study 25072405 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy administered in-person (CBT-IP)
Number of subjects: 100
Study 25072405 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 100
Study 23910207 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-ligating brackets
Number of subjects: 20
Study 23910207 — intervention group
Group type: COMPARATOR
Intervention: Conventional brackets ligated with stainless steel ligatures
Number of subjects: 20
Study 23910207 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (self-ligating and conventional brackets)
Number of subjects: 20
Study 21764705 — intervention group
Group type: EXPERIMENTAL
Intervention: Ephedrine
Number of subjects: 40
Study 21764705 — intervention group
Group type: COMPARATOR
Intervention: Pre‐anesthetic volume with Voluven
Number of subjects: 40
Study 18435723 — intervention group
Group type: EXPERIMENTAL
Intervention: Trident White (TW) gum
Number of subjects: 10
Study 18435723 — intervention group
Group type: EXPERIMENTAL
Intervention: Orbit gum
Number of subjects: 10
Study 16499515 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine depot injection (58 mg)
Number of subjects: 11
Study 12910861 — intervention group
Group type: EXPERIMENTAL
Intervention: Foot-pump (A-V Impulse System)
Number of subjects: 106
Study 12910861 — intervention group
Group type: COMPARATOR
Intervention: Low molecular weight heparin (Fraxiparin)
Number of subjects: 106
Study 10884451 — intervention group
Group type: EXPERIMENTAL
Intervention: rTPA (0.9 mg/kg IV)
Number of subjects: 52
Study 10884451 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 9333327 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose dopamine (1-3 μg x kg-1 x min-1)
Number of subjects: 0
Study 9333327 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine administration of low-dose dopamine
Number of subjects: 0
Study 8480823 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent behavioral treatment
Number of subjects: 38
Study 8480823 — intervention group
Group type: COMPARATOR
Intervention: Drug abuse counseling
Number of subjects: 38